The insider selling is too small in dollar terms to signal a bearish view. Monitor for any larger insider sales or changes in fundamentals (e.g., upcoming pipeline readouts or earnings) that could drive price action. No immediate trading action warranted.
DNLI drugs
DNLI drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 8 $22.08entry
- T+1 · 2mo ago −2.31%α −1.84% · $21.57
- T+5 · 2mo ago −7.70%α −6.58% · $20.38
- T+20 · 6w ago −12.68%α −14.40% · $19.28
- T+49 · todayOpen
- T+60 · in 15d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Denali Therapeutics insiders (COFO/Secretary Schuth and Director Thornberry) sold a combined $312K in open-market transactions over a 2-day window. The total value represents only ~0.009% of the company's $3.6B market cap, a trivial amount that does not convey material negative information.
Key Financial Metrics
Key Facts
- Total insider sales: $312K across 2 insiders (Schuth $65K, Thornberry $247K)
- Sales represent ~0.009% of DNLI's $3.6B market cap, well below the 0.1% materiality threshold
- Both transactions were open-market sells; no 10b5-1 plan indicated
- No insider purchases in the cluster to offset the selling
Financial Impact
Trivial, $312K in sales is immaterial relative to $3.6B market cap
Risk Factors
- Insider selling could accelerate if management becomes more bearish on upcoming catalysts
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-DNLI-1788555777764 |
Track record
17 reports on DNLI
3 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +23.19% at T+60 after the May 7, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $18.75 Now $18.08 −3.55% settles Nov 17
- Nov 3, 202613d ago 8-K Bullish 6/10 No price data
- Nov 3, 202613d ago Press Release Neutral 5/10 Entry $20.96 to $19.72 Now $18.08 −13.74% ▼ −5.92% −1.51% vs SPY
- Oct 30, 202617d ago Press Release Neutral 3/10 Entry $18.94 to $18.86 Now $18.08 −4.54% ▼ −0.42% +0.06% vs SPY
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $18.66 Now $18.08 −3.11% No price data
- Sep 9, 20269w ago Insider Cluster Neutral 2/10 Entry $21.40 to $21.09 Now $18.08 −15.51% ▼ −1.45% −2.30% vs SPY
- Sep 4, 202610w ago Insider Cluster Neutral 2/10 Viewing Entry $22.08 to $21.57 Now $18.08 −18.12% ▼ −2.31% −1.84% vs SPY
- Aug 6, 202614w ago 8-K Mixed 6/10 Entry $24.83 to $25.00 Now $18.08 −27.18% ▲ +0.68% +0.71% vs SPY
- Jul 27, 202616w ago Press Release Neutral 1/10 Entry $24.05 Now $18.08 −24.82% No price data
- Jun 18, 202621w ago 8-K Bullish 6/10 Entry $23.31 to $24.05 Now $18.08 −22.44% ▲ +3.17% +3.49% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers